Eingabe löschen

Kopfbereich

Schnellnavigation

Hauptnavigation

TEDD Competence Centre - Tissue Engineering for Drug Development and Substance Testing

Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement) in the long term.

EVENT SUMMARY: TEDD University Visit to EPFL AGORA Translational Cancer Research Center

TEDD expands its interest towards translational medicine.  Hence, this event presented the AGORA translational research environment and multidisciplinary community that brings together cancer biologists, clinicians, bio-informaticians & bioengineers. Our community could learn how such integrated & collaborative ecosystem enables the translational development of new therapeutic strategies to support patients.

EVENT SUMMARY

Next TEDD Visit March 2023

NEW TEDD Partner sallea (ETH Zürich)

We welcome a new TEDD Partner!
sallea is an ETH based start-up with a novel platform technology to manufacture porous, 3-dimensional structures targeted for 3D cell scaffolds. These scaffolds are targeted for applications such as drug screening or to cultivate meat in-vitro and may be extended towards regenerative medicine and tissue engineering.

TEDD Partners

TEDD Partnership Fee 2023

Yearly TEDD Partnership fee 2023 is CHF 500.

TEDD Partnership conditions:

  • Two people from TEDD Partner organization can attend TEDD events free of charge. Subsequent people from this organization will receive a 50% discount for that event.
  • TEDD Partnership period is from January to December of the given year.
  • TEDD Partnership extends for the following year unless cancelled.
  • TEDD Partner can cancel partnership latest on 30 November of the current year effective next year by sending us an email on info.tedd@zhaw.ch.

Join TEDD as Partner

TEDD Visits 2022

About TEDD

TEDD Competence Centre (Tissue Engineering for Drug Development and Substance Testing)

TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.

Read more about TEDD

TEDD Flyer(PDF 1,1 MB)

Events

News